Adenosine A1 receptor antagonists in the kidney: Effects in fluid-retaining disorders

Current Opinion in Pharmacology

Volumn 2, Issue 2, 2002, Pages 165-170

  Welch, William J ^a  

^a GEORGETOWN UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

3,7 DIMETHYL 1 PROARGYLXANTHINE; 5' NUCLEOTIDASE; 6 OXO 3 (2 PHENYLPYRAZOLO[1,5 A]PYRIDIN 3 YL) 1(6H) PYRIDAZINEBUTYRIC ACID; 8 (2 NOR 1 ADAMANTYL) 1,3 DIPROPYLXANTHINE; 8 (3,4 DIMETHOXYSTYRYL) 7 METHYL 1,3 DIPROPYLXANTHINE; 8 CYCLOPENTYL 1,3 DIPROPYLXANTHINE; ADENOSINE; ADENOSINE A1 RECEPTOR ANTAGONIST; ADENOSINE A2 RECEPTOR; AMINOPHYLLINE; CONTRAST MEDIUM; DIATRIZOATE; DOPAMINE RECEPTOR; ENDOTOXIN; FUROSEMIDE; GUANINE NUCLEOTIDE BINDING PROTEIN; IOTROLAN; LIPOPOLYSACCHARIDE; LOOP DIURETIC AGENT; METHYLXANTHINE; NAXIFYLLINE; NITRIC OXIDE; NITRIC OXIDE SYNTHASE INHIBITOR; PERTUSSIS TOXIN; POTASSIUM SPARING DIURETIC AGENT; SODIUM; SODIUM CHLORIDE; THEOPHYLLINE; UNCLASSIFIED DRUG; UNINDEXED DRUG; XANTHINE DERIVATIVE; ADENOSINE RECEPTOR;

ACUTE KIDNEY FAILURE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIHYPERTENSIVE ACTIVITY; ARTICLE; AUTOREGULATION; CONGESTIVE HEART FAILURE; CONTROLLED STUDY; DIURESIS; DOSE RESPONSE; DRUG EFFICACY; DRUG INDUCED DISEASE; DRUG SELECTIVITY; FLUID BALANCE; FLUID RETENTION; GLOMERULUS FILTRATION RATE; HUMAN; KIDNEY FUNCTION; MOUSE; NATRIURESIS; NONHUMAN; POSTOPERATIVE COMPLICATION; PRIORITY JOURNAL; RAT; VASOCONSTRICTION; ANIMAL; DRUG ANTAGONISM; DRUG EFFECT; ELECTROLYTE BALANCE; KIDNEY; PHYSIOLOGY; REVIEW; VASCULARIZATION;

ANIMALS; HUMANS; KIDNEY; RECEPTORS, PURINERGIC P1; WATER-ELECTROLYTE BALANCE;

EID: 0036525756     PISSN: 14714892     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1471-4892(02)00134-0     Document Type: Review

References (24)

1. CVT-124, a novel adenosine A1 receptor antagonist with unique diuretic activity
2. Natriuretic and diuretic actions of a highly selective adenosine A1 receptor antagonist
3. Effects of BG9719 (CVT-124), an A1-adenosine receptor antagonist, and furosemide on glomerular filtration rate and natriuresis in patients with congestive heart failure
4. BG9719 (CVT-124), an A1-adenosine receptor antagonist, protects against the decline in renal function observed with standard diuretic therapy
5. A pilot study to investigate the effects of an infusion of aminophylline on renal function following major abdominal surgery
6. Adenosine and renal sodium handling: Direct natriuresis and renal nerve-mediated antinatriuresis
7. The effects of adenosine on water and sodium excretion
8. Role of renal medullary adenosine in the control of blood flow and sodium excretion
9. 1 receptor blockade in normotensive and SHR: Role of pertussis toxin-sensitive G-proteins
10. Adenosine activates aromatic L-amino acid decarboxylase activity in the kidney and increases dopamine
11. Effect of the selective adenosine A1-receptor antagonist KW-3902 on lipopolysaccharide-induced reductions in urine volume and renal blood flow in anesthetized dogs
12. Role of adenosine in contrast media-induced acute renal failure in diabetes mellitus
13. Effects of adenosine receptor antagonists on the responses to contrast media in the isolated rat kidney
14. Role of adenosine in the renal response to contrast medium
15. Synergistic effects of angiotensin and adenosine in the renal microvasculature
16. Effect of the selective adenosine A1 receptor antagonist KW-3902 on TGF in radiocontrast media-induced nephropathy in rats with chronic NO deficiency
17. The selective adenosine A1 receptor antagonist KW-3902 prevents radiocontrast media-induced nephropathy in rats with chronic nitric oxide deficiency
18. Mediation of tubuloglomerular feedback by adenosine: Evidence from mice lacking adenosine 1 receptors
19. Abolished tubuloglomerular feedback and increased plasma renin in adenosine A1 receptor-deficient mice
20. Adenosine formed by 5′-nucleotidase mediates tubuloglomerular feedback
21. Interactions of adenosine A1 and A2a receptors on renal microvascular reactivity
22. Efferent arteriole TGF in the renal nephron
23. Adenosine (A1) receptor antagonist KW-3902 prevents hypoxia-induced renal vasoconstriction
24. Evidence that the renin release decrease during hypoxia is adenosine mediated in conscious dogs